PCSK9 and atherosclerosis: Given that SR-B1 single KO mice possess intact mechanisms for LDL and VLDL clearance from the blood stream, they may prove a useful model of experimental atherosclerosis that is suitable for testing therapeutic agents, such as statins and PCSK9 inhibitors, which rely on the enhancement of this system as a mechanism for cholesterol lowering.